Results 81 to 90 of about 299,261 (256)

The General Data Protection Regulation Between Normative Evolution and Data Governance Management

Robotica & Management
The General Data Protection Regulation (GDPR) represents the central pillar of European data governance, instituting the transition from a formal–procedural compliance approach to a model based on accountability, transparency and continuous risk ...
Claudia Pau, Mihaela Martin, Alina Stancovici   +2 more
doaj   +1 more source

Enablers and barriers to the secondary use of health data in Europe: general data protection regulation perspective. [PDF]

Arch Public Health, 2022
Vukovic J, Ivankovic D, Habl C, Dimnjakovic J.   +3 more
europepmc   +1 more source

Digital Cognitive Testing in Mitochondrial Disease: Validity and Challenges for Clinical Trial Use

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Primary mitochondrial disease is a group of genetic disorders caused by pathogenic variants in nuclear or mitochondrial DNA, often resulting in progressive neurodegeneration and cognitive decline. Current management is primarily supportive, though recent research offers hope for disease‐modifying treatments in the future.
Oksana Pogoryelova, Jan Smeitink, Herma Renkema, Rosabeth White, Frankie Barton, Rachel Lyon, Jane Newman, Aye Moe, Yi Shiau Ng, Grainne Siobhan Gorman   +9 more
wiley   +1 more source

Perbandingan Normatif Regulasi Perlindungan Data Pribadi Amerika Serikat dan GDPR Uni Eropa dalam Perspektif Transfer Data Lintas Batas

Begawan Abioso
Perkembangan era digital global telah menjadikan perlindungan data pribadi sebagai isu hukum yang sangat krusial, terutama akibat kemajuan teknologi kecerdasan buatan dan meningkatnya intensitas serangan siber.
Josua Ferdinand Sihotang
doaj   +1 more source

Measuring data access and re-use in the European Legal Framework for Data, from the General Data Protection Regulation (GDPR) law to the Proposed Data Act: the case of vehicle data. [PDF]

Open Res Eur, 2023
Crepax T, Gaur M, da Rosa Lazarotto B.
europepmc   +1 more source

Judicial and Technical Improvement of General Data Protection Regulation

, 2020
The issue of personal data protection of natural persons has been in the focus of the world public for years. Well-known data processors and controllers are often the target of attacks on their information systems, which is why personal data of millions of users ends up in unauthorized hands.
Dakić, Vedran, Ribarić, Sanja
openaire   +1 more source

Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Diabetes‐associated cognitive impairment (DACI) is a common yet underrecognized condition, manifesting along a spectrum from mild cognitive impairment to dementia. DACI encompasses patients who develop vascular dementia (VaD) or Alzheimer's disease (AD) with diabetes as a risk factor; however, in certain patients, particularly those lacking ...
Osman Corbali, Priyanka Menon, Halil I. Corbali, Ram Jagannathan, Allan I. Levey   +4 more
wiley   +1 more source

Data Sharing Under the General Data Protection Regulation: Time to Harmonize Law and Research Ethics? [PDF]

Hypertension, 2021
Vlahou A, Hallinan D, Apweiler R, Argiles A, Beige J, Benigni A, Bischoff R, Black PC, Boehm F, Céraline J, Chrousos GP, Delles C, Evenepoel P, Fridolin I, Glorieux G, van Gool AJ, Heidegger I, Ioannidis JPA, Jankowski J, Jankowski V, Jeronimo C, Kamat AM, Masereeuw R, Mayer G, Mischak H, Ortiz A, Remuzzi G, Rossing P, Schanstra JP, Schmitz-Dräger BJ, Spasovski G, Staessen JA, Stamatialis D, Stenvinkel P, Wanner C, Williams SB, Zannad F, Zoccali C, Vanholder R.   +38 more
europepmc   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source